EP Patent

EP2603514A1 — Cyclic boronic acid ester derivatives and therapeutic uses thereof

Assigned to Rempex Pharmaceuticals Inc · Expires 2013-06-19 · 13y expired

What this patent protects

Disclosed herein are antimicrobial compound compositions, pharmaceutical compositions, the use and preparation thereof. The invention relates to cyclic boronic acid ester derivatives of formula I and their use as therapeutic agents particularly in the treatment of bacterial infec…

USPTO Abstract

Disclosed herein are antimicrobial compound compositions, pharmaceutical compositions, the use and preparation thereof. The invention relates to cyclic boronic acid ester derivatives of formula I and their use as therapeutic agents particularly in the treatment of bacterial infections.

Drugs covered by this patent

Patent Metadata

Patent number
EP2603514A1
Jurisdiction
EP
Classification
—
Expires
2013-06-19
Drug substance claim
No
Drug product claim
No
Assignee
Rempex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.